Todd Berg


Todd joined Metavention in January 2018 and serves as Chief Executive Officer. Todd has over 25 years of experience in the medical device industry. Prior to Metavention, he was founder, President and CEO of Torax Medical until its acquisition by Johnson & Johnson in 2017. Prior to that, Todd was with St. Jude Medical, where he was the Vice President of Emerging Technology. He joined St. Jude Medical through the acquisition of Vascular Science in 1999 where he was the Vice President of Research and Development. Previous to Vascular Science, he was with SciMed Life Systems and Boston Scientific.

Todd holds over 60 patents in the area of medical technology. He received a Bachelor of Science degree in mechanical engineering from the University of Minnesota.